Milder phenotypes of glucose transporter type 1 deficiency syndrome [PDF]
Glucose transporter type 1 deficiency syndrome (GLUT1DS) is a treatable condition resulting from impaired glucose transport into the brain. The classical presentation is with infantile-onset epilepsy and severe developmental delay. Non-classical phenotypes with movement disorders and early-onset absence epilepsy are increasingly recognized and the ...
Anand, G.+14 more
openaire +5 more sources
Nearly 90% of patients with glucose transporter type 1 deficiency syndrome (Glut1 DS; figure) have paroxysmal or constant gait abnormalities, including ataxic, spastic, ataxic-spastic, and dystonic gait.1,2 We report 3 cases of genetically proven Glut1 DS (table) demonstrating a distinctive paroxysmal gait disorder triggered by exertion or fasting ...
Francesca Magrinelli+9 more
openaire +3 more sources
Aims: Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors play a key role in the treatment of type 2 diabetes mellitus.
Chen Li+7 more
doaj +1 more source
Effect of duodenal-jejunal bypass on diabetes in the early postoperative period
Metabolic surgery is an effective treatment for patients with type 2 diabetes mellitus (T2DM). The aim of this study was to investigate the effect of duodenal-jejunal bypass (DJB) in a rat model of T2DM during the early postoperative period.
Shohei Okikawa+8 more
doaj +1 more source
Increased Glucose Availability Attenuates Myocardial Ketone Body Utilization
Background Perturbations in myocardial substrate utilization have been proposed to contribute to the pathogenesis of cardiac dysfunction in diabetic subjects.
Manoja K. Brahma+10 more
doaj +1 more source
Translocation of the brain-type glucose transporter largely accounts for insulin stimulation of glucose transport in BC3H-1 myocytes [PDF]
Insulin-stimulated glucose transport was examined in BC3H-1 myocytes. Insulin treatment lead to a 2.7 +/- 0.3-fold increase in the rate of deoxyglucose transport and, under the same conditions, a 2.1 +/- 0.1-fold increase in the amount of the brain-type glucose transporter (GLUT 1) at the cell surface.
D M Calderhead+3 more
openaire +3 more sources
An Unusual Presentation of Glucose Transporter Type 1 Deficiency Syndrome [PDF]
AbstractGlucose serves as the major energy sources for developing brain. In the resting state, the adult brain can consume up to 25% of the body's total glucose supply, while in infants and children it can use as much as 80%. Glucose entry into brain occurs via glucose transporter proteins GLUTs). They are five GLUTs protein.
G Saritha, S Bhavani
openaire +1 more source
Exercise training-induced PPARβ increases PGC-1α protein stability and improves insulin-induced glucose uptake in rodent muscles [PDF]
This study aimed to investigate the long-term effects of training intervention and resting on protein expression and stability of peroxisome proliferator-activated receptor β/δ (PPARβ), peroxisome proliferator-activated receptor gamma coactivator 1-α ...
Holloszy, John O+3 more
core +2 more sources
A Different SLC2A1 Gene Mutation in Glut 1 Deficiency Syndrome: c.734A>C
Background: Glucose transporter type 1 deficiency syndrome is the result of impaired glucose transport into the brain. Patients with glucose transporter type 1 syndrome may present with infantile seizures, developmental delay, acquired microcephaly ...
Rüya Çolak+4 more
doaj +1 more source
Hippocampal Neurochemical Profile and Glucose Transport Kinetics in Patients With Type 1 Diabetes [PDF]
Abstract Context Longstanding type 1 diabetes (T1D) may lead to alterations in hippocampal neurochemical profile. Upregulation of hippocampal glucose transport as a result of recurrent exposure to hypoglycemia may preserve cognitive function during future hypoglycemia in subjects with T1D and impaired
Petr Bednařík+9 more
openaire +4 more sources